BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20082230)

  • 1. Amyloid-plaque imaging in early and differential diagnosis of dementia.
    Drzezga A
    Ann Nucl Med; 2010 Feb; 24(2):55-66. PubMed ID: 20082230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic pathologies of neurodegenerative dementias and their relevance for state-of-the-art molecular imaging studies.
    Drzezga A
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S4-11. PubMed ID: 18197407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical amyloid imaging in Alzheimer's disease.
    Herholz K; Ebmeier K
    Lancet Neurol; 2011 Jul; 10(7):667-70. PubMed ID: 21683932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of amyloid in Alzheimer's disease.
    Nordberg A
    Lancet Neurol; 2004 Sep; 3(9):519-27. PubMed ID: 15324720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Visualization of amyloid with positron emission tomography. Useful improvement in the diagnosis of dementia?].
    Grimmer T; Drzezga A; Kurz A
    Nervenarzt; 2010 May; 81(5):602-6. PubMed ID: 20221742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease.
    Kudo Y
    Minim Invasive Ther Allied Technol; 2006; 15(4):209-13. PubMed ID: 16966133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of molecular imaging research to innovative drug development].
    Shimada H
    Rinsho Shinkeigaku; 2014; 54(12):1174-7. PubMed ID: 25672737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain amyloid imaging.
    Rowe CC; Villemagne VL
    J Nucl Med Technol; 2013 Mar; 41(1):11-8. PubMed ID: 23396994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid imaging in Alzheimer's disease and other dementias.
    Fodero-Tavoletti MT; Cappai R; McLean CA; Pike KE; Adlard PA; Cowie T; Connor AR; Masters CL; Rowe CC; Villemagne VL
    Brain Imaging Behav; 2009 Sep; 3(3):246-61. PubMed ID: 22005989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.
    Villemagne VL; Rowe CC; Macfarlane S; Novakovic KE; Masters CL
    J Clin Neurosci; 2005 Apr; 12(3):221-30. PubMed ID: 15851069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
    Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
    Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain burdens of aluminum, iron, and copper and their relationships with amyloid-β pathology in 60 human brains.
    Exley C; House E; Polwart A; Esiri MM
    J Alzheimers Dis; 2012; 31(4):725-730. PubMed ID: 22699848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications.
    Laforce R; Rabinovici GD
    Alzheimers Res Ther; 2011 Nov; 3(6):31. PubMed ID: 22071129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular Inference in Dementia Diagnostics.
    Høilund-Carlsen PF; Barrio JR; Gjedde A; Werner TJ; Alavi A
    J Alzheimers Dis; 2018; 63(1):69-73. PubMed ID: 29504544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
    Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
    J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.